---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-017114"
form_type: "8-K"
ticker: null
cik: "0001697532"
company_name: "Applied Therapeutics, Inc."
filed_at: "2025-02-10T23:59:59+00:00"
generated_at: "2026-05-27T00:10:01.793855+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Applied Therapeutics receives Nasdaq deficiency notice for bid price below $1; cure period through Aug 6, 2025

## Summary
- Nasdaq notified APLT on Feb 7, 2025 that closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Aug 6, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by Aug 6, APLT may transfer to Nasdaq Capital Market for an additional 180-day grace period.
- APLT is evaluating options but has not yet decided on a response; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0000950170-25-017114
- form_type: 8-K
- cik: 0001697532
- company_name: Applied Therapeutics, Inc.
- filed_at: 2025-02-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1697532/000095017025017114/0000950170-25-017114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1697532/000095017025017114/aplt-20250207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-017114
- JSON: https://secwatch.observer/filing/0000950170-25-017114.json
- Plain text: https://secwatch.observer/filing/0000950170-25-017114.txt

## Source-grounded claims
- claim_id: 4073f0c09ff29d64f5843feb30bf7f058536f683
  claim: Applied Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  evidence_excerpt: February 7, 2025, Applied Therapeutics, Inc. (the “ Company ”) received written notification (the “ Notice ”) from the Nasdaq Stock Market (“ Nasdaq ”) that, because the closing bid price for the Company’s common stock h
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697532/000095017025017114/0000950170-25-017114-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.